Work

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehr113

Authors: J. Oldgren, A. Budaj, C. B. Granger, Y. Khder, J. Roberts, A. Siegbahn, J. G. P. Tijssen, F. Van de Werf, L. Wallentin, for the RE-DEEM Investigators

Institutions: Uppsala University, Grochowski Hospital, Duke Clinical Research Institute, Boehringer Ingelheim (France), Boehringer Ingelheim (United Kingdom), Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Universitair Ziekenhuis Leuven

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2098837786

FWCI: 47.86

Cites: 27

Cited by: 539

Related to: 10